Tag: LDL reduction

Alternative Cholesterol Medications: Ezetimibe and Bempedoic Acid for Statin-Intolerant Patients

Alternative Cholesterol Medications: Ezetimibe and Bempedoic Acid for Statin-Intolerant Patients

Ezetimibe and bempedoic acid offer effective, oral alternatives for people who can't tolerate statins. Both lower LDL cholesterol and reduce heart risks, with ezetimibe being affordable and bempedoic acid offering proven cardiovascular benefits.

RECENT POSTS

November 19, 2025
How to Verify Drug Authenticity: Official Tools and Resources You Can Trust

Learn how to verify if your medicine is real using official tools like EU FMD and U.S. DSCSA systems. Spot counterfeit drugs and protect yourself with proven methods and expert tips.

April 4, 2026
Authorized Generics: How Brand Drug Makers Launch Their Own Generic Versions

Discover how pharmaceutical companies use 'authorized generics' to maintain market share and revenue after their drug patents expire.

October 17, 2025
Rickets and Exercise: Why Physical Activity Is Key for Strong Bones

Discover how regular exercise works with vitamin D and calcium to fight rickets, boost bone density, and keep children's skeletons strong and healthy.

May 9, 2023
The role of cycloserine in multidrug-resistant tuberculosis management

In my latest blog post, I discussed the crucial role of cycloserine in managing multidrug-resistant tuberculosis (MDR-TB). Cycloserine, an antibiotic, has become increasingly important in the treatment of MDR-TB, especially when other first-line medications are ineffective. This is because it targets the bacteria causing TB in a different way, thus overcoming resistance. However, it's essential to use cycloserine in combination with other antibiotics to ensure maximum effectiveness and minimize the risk of further resistance. Overall, cycloserine plays a vital role in the fight against MDR-TB, and ongoing research is crucial to optimize its use and develop new treatments.

January 22, 2026
Medicare Drug Coverage and Cost Assistance Options in 2025-2026

Medicare Part D now has a $2,000 annual cap on drug costs in 2025, eliminating the donut hole. Learn how Extra Help, plan choices, and insulin pricing work for seniors on prescription meds.